Avanish Vellanki - 01 Jun 2022 Form 4 Insider Report for Rain Therapeutics Inc.

Role
Chairman and CEO, Director, 10%+ Owner
Signature
/s/ Nelson Cabatuan, Attorney-in-fact for Avanish Vellanki
Issuer symbol
N/A
Transactions as of
01 Jun 2022
Net transactions value
+$57,250
Form type
4
Filing time
02 Jun 2022, 16:05:41 UTC
Previous filing
15 Apr 2022
Next filing
17 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RAIN Common Stock Purchase $57,250 +25,000 +1% $2.29 2,471,627 01 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $2.285 to $2.3268. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.